XML 46 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2020
Cisneros Interactive  
Reconciliation of Changes in Redeemable Noncontrolling Interests The table below presents the reconciliation of changes in redeemable noncontrolling interests (in thousands):

 

Years Ended December 31,

 

 

2020

 

 

2019

 

 

2018

 

Beginning balance

$

-

 

 

$

-

 

 

$

-

 

Initial fair value of redeemable noncontrolling interests

 

30,762

 

 

 

-

 

 

 

-

 

Net income (loss) attributable to redeemable noncontrolling interest

 

2,523

 

 

 

-

 

 

 

-

 

Ending balance

$

33,285

 

 

$

-

 

 

$

-

 

 

Summary of Purchase Price Allocation The following is a summary of the purchase price allocation (in millions):

 

Cash  

$

8.7

 

Accounts receivable  

 

50.5

 

Other assets  

 

6.2

 

Intangible assets subject to amortization

 

41.7

 

Goodwill

 

12.3

 

Current liabilities  

 

(48.1

)

Deferred tax

 

(10.6

)

Redeemable noncontrolling interest

 

(30.8

)

Summary of Intangible Assets Subject to Amortization Acquired

Intangibles assets subject to amortization acquired includes:

 

Intangible Asset

Estimated

Fair Value

(in millions)

 

Weighted

average

life (in years)

 

Publisher relationships

$

34.4

 

10.0

 

Advertiser relationships

 

5.2

 

4.0

 

Trade name

 

1.7

 

2.5

 

Non-Compete agreements

 

0.4

 

4.0

 

Schedule of Unaudited Pro Forma Information

The following unaudited pro forma information for the years ended December 31, 2020 and 2019 has been prepared to give effect to the acquisition of a majority interest in Cisneros Interactive as if the acquisition had occurred on January 1, 2019. This pro forma information was adjusted to exclude acquisition fees and costs of $0.9 million for the year ended December 31, 2020, which were expensed in connection with the acquisition. This pro forma information does not purport to represent what the actual results of operations of the Company would have been had this acquisition occurred on such date, nor does it purport to predict the results of operations for any future periods.

 

 

Years Ended

 

 

Ended December 31,

 

 

2020

 

 

2019

 

Pro Forma:

 

 

 

 

 

 

 

Total revenue

$

488,137

 

 

$

432,966

 

Net income (loss)

 

5,257

 

 

 

(11,403

)

Net income (loss) attributable to redeemable noncontrolling interest

 

(5,343

)

 

 

(4,071

)

Net income (loss) attributable to common stockholders

$

(86

)

 

$

(15,474

)

 

 

 

 

 

 

 

 

Basic and diluted earnings per share:

 

 

 

 

 

 

 

Net income (loss) per share, attributable to common stockholders, basic and diluted

$

0.00

 

 

$

(0.18

)

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding, basic and diluted

 

84,231,212

 

 

 

85,107,301

 

Smadex  
Summary of Purchase Price Allocation

The following is a summary of the final purchase price allocation for the Company’s acquisition of Smadex (in millions):

 

Accounts receivable

$

0.9

 

Other current assets

 

0.4

 

Intangible assets subject to amortization

 

2.0

 

Goodwill

 

3.6

 

Current liabilities

 

(2.8

)

Long-term liabilities

 

(0.2

)

Deferred tax

 

(0.4

)

Schedule of Unaudited Pro Forma Information

The following unaudited pro forma information for the years ended December 31, 2018 and 2017 has been prepared to give effect to the acquisition of Smadex as if the acquisition had occurred on January 1, 2017.  This pro-forma information does not purport to represent what the actual results of operations of the Company would have been had this acquisition occurred on such date, nor does it purport to predict the results of operations for future periods.

 

 

Years Ended

December 31,

 

 

2018

 

Pro Forma:

 

 

 

Total revenue

$

307,805

 

Net income (loss)

$

13,133

 

 

 

 

 

Basic and diluted earnings per share:

 

 

 

Net income per share, basic

$

0.15

 

Net income per share, diluted

$

0.15

 

 

 

 

 

Weighted average common shares outstanding, basic

 

89,115,997

 

Weighted average common shares outstanding, diluted

 

90,328,583